Vesicular phospholipid gels: A technology platform

Journal of Liposome Research

Volumn 17, Issue 1, 2007, Pages 15-26

  Brandl, Martin ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Depot; Encapsulation efficiency; Liposome loading; Particle size distribution; Permeability; Small unilamellar vesicle (SUV); Sustained release; Vesicle morphology

Indexed keywords

CARBOPLATIN; CETRORELIX; FLUOROURACIL; GEMCITABINE; LIPOSOME; PHOSPHOLIPID; VINCRISTINE;

AQUEOUS SOLUTION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED DRUG RELEASE; DIFFUSION; DILUTION; DISPERSION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; ENCAPSULATION; GEL; HYDRATION; HYDROLYSIS; HYDROPHILICITY; IMPLANT; LIPID BILAYER; LIPID VESICLE; LIPOPHILICITY; PARTICLE SIZE; PASSIVE TRANSPORT; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GELS; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LIPOSOMES; NEOPLASMS; PARTICLE SIZE; PHOSPHOLIPIDS;

EID: 34247366412     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100601186490     Document Type: Article

References (34)

1. Bachmann, D., Brandl, M., Gregoriadis, G. (1993). Preparation of liposomes using a Mini-Lab 8.30 H high-pressure homogenizer. Int. J. Pharm. 91(1):69-74.
2. Beijnen, J. H., Van der Houwen, O. A. G. J., Underberg, W. J. M. (1986). Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int. J. Pharm. 32(2-3):123-131.
3. Bender, J. (2000). Vesikuläre Phospholipidgele: Herstellungsmethoden, Dispergierverhalten, Lagerstabilität und physikalische Charakterisierung. Diss. rer. nat. Freiburg, Albert-Ludwigs- Universität: 117.
4. Brandl, M. (1998). High-pressure homogenization techniques for the production of liposome dispersions: potential and limitations. In: Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs, Based on the Invited Lectures and Communications presented at the Colloidal Drug Carriers Expert Meeting, 3rd, Berlin, May 29-31, 1997, pp. 267-294.
5. Brandl, M. (2001). Liposomes as drug carriers: a technological approach. Biotechno. Ann. Rev. 7: 59-85.
6. Brandl, M., Bachmann, D., Drechsler, M., Bauer, K. H. (1990). Liposome preparation by a new high pressure homogenizer Gaulin Micron LAB 40. Drug Dev. Ind. Pharm. 16(14): 2167-2191.
7. Brandl, M., Bachmann, D., Reszka, R., Drechsler, M. (1996a). Liposomal carrier for active agents. Application: DE, (Max-Delbrueck-Centrum fuer Molekulare Medizin, Germany). 7 pp.
8. Brandl, M., Bachmann, D., Reszka, R., Drechsler, M. (2002). Unilamellar vesicular lipids for liposomal preparations with high active substance content. Application: US, (Max-Delbrueck-Centrum Fuer Molekulare Medizin, Germany). 14 pp., Cont-in-part of Appl. No PCT/DE95/01162.
9. Brandl, M., Drechsler, M., Bachmann, D., Bauer, K.-H. (1997). Morphology of semisolid aqueous phosphatidylcholine dispersions, a freeze fracture electron microscopy study. Chem. Phys. Lip. 87(1):65-72.
10. Brandl, M., Drechsler, M., Bachmann, D., Bauer, K. H. (1996b). Three-dimensional networks of liposomes: preparation and electron microscopical characterization. Proc. International Symposium on Controlled Release of Bioactive Materials 23:25-26.
11. Brandl, M., Drechsler, M., Bachmann, D., Tardi, C., Schmidtgen, M., Bauer, K.-H. (1998). Preparation and characterization of semi-solid phospholipid dispersions and dilutions thereof. Int. J. Pharm. 170(2):187-199.
12. Brandl, M., Massing, U. (2003). Vesicular phospholipid gels. Liposomes. Torchilin, V. P. and Weisssig, V. Oxford: Oxford Press, pp. 353-372.
13. Brandl, M., Reszka, R. (1995). Preparation and characterization of phospholipid membrane gels as depot formulations for potential use as implants. Proc. International Symposium on Controlled Release of Bioactive Materials 22: 472-473.
14. Brandl, M. M., Bachmann, D., Drechsler, M., Bauer, K. H. (1993). Liposome preparation using high-pressure homogenizers. Liposome Technology (2nd Ed.) 1:49-65.
15. Flaten, G. E., Dhanikula, A. B., Luthman, K., Brandl, M. (2006). Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion. Eur. J. Pharm. Sci. 27(1):80-90.
16. Grohganz, H. (2004). Vesicular phospholipid gels as a potential implant system for cetrorelix. Dr.scient.-thesis. Tromsoe, University of Tromsoe, p. 72.
17. Grohganz, H., Rischer, M., Brandl, M. (2004a). Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface. Eur. J. Pharm. Sci. 21(2-3):191-196.
18. Grohganz, H., Schlafli, O., Rischer, M., Brandl, M. (2004b). Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions. J. Pharm. Biomed. Anal. 34(5):963-969.
19. Grohganz, H., Tho, I., Brandl, M. (2005). Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix. Eur. J. Pharm. Biopharm. 59(3):439-448.
20. Grohganz, H., Ziroli, V., Massing, U., Brandl, M. (2003). Quantification of various phosphatidylcholines in liposomes by enzymatic assay. AAPS Pharm. Sci. Tech. 4(4):E63.
21. Guethlein, F. (2001). Darstellung und Pruefung von vesikulaeren Phospholipidgelen (VPG) zur Therapie solider Tumoren. Diss. rer. nat. Freiburg, Albert-Ludwigs-Universitaet, p. 195.
22. Ingebrigtsen, L., Brandl, M. (2002). Determination of the size distribution of liposomes by SEC fractionation, and PCS analysis and enzymatic assay of lipid content. AAPS Pharm. Sci. Tech 3(2):E7.
23. Moog, R. (1998). Einschluss von Gemcitabin (dFdC) in vesikuläre Phospholipidgele. Diss. rer. nat. Freiburg, Albert-Ludwigs-Universität: p. 155.
24. Moog, R., Brandl, M., Schubert, R., Unger, C., Massing, U. (2000). Effect of nucleoside analogs and oligonucleotides on hydrolysis of liposomal phospholipids. Int. J. Pharm. 206(1-2):43-53.
25. Patel, V. B., Misra, A., Marfatia, Y. S. (2000). Topical liposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm. Dev. Techno. 5(4):455-464.
26. Pavelic, Z., Skalko-Basnet, N., Schubert, R. (2001). Liposomal gels for vaginal drug delivery. Int. J. Pharm. 219(1-2):139-149.
27. Paavola, A., Kilpelainen, I., Yliruusi, J., Rosenberg, P. (2000). Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int. J. Pharm. 199(1):85-93.
28. Saetern, A. M., Skar, M., Braaten, A., Brandl, M. (2005). Camptothecin-catalyzed phospholipid hydrolysis in liposomes. Int. J. Pharm. 288(1):73-80.
29. Schneider, T., Sachse, A., Roessling, G., Brandl, M. (1994). Large-scale production of liposomes of defined size by a new continuous high pressure extrusion device. Drug Dev. Ind. Pharm. 20(18):2787-2807.
30. Sætern, A. M. (2004). Parenteral liposome- and cyclodextrin formulations of camptothecin. Dr. scient.-thesis. Tromsoe, University of Tromsoe, p. 58.
31. Tardi, C. (1999). Vesikuläre Phospholipidgele: in-vitro Charakterisierung, Autoklavierbarkeit, Anwendung als Depotarzneiform. Diss. rer. nat. Freiburg, Albert-Ludwigs-Universität, p. 103.
32. Tardi, C., Brandl, M., Schubert, R. (1998). Erosion and controlled release properties of semisolid vesicular phospholipid dispersions. J. Contr. Rel. 55(2,3):261-270.
33. Tardi, C., Drechsler, M., Schubert, R., Brandl, M. (1996). Three-dimensional networks of liposomes: change of properties upon autoclaving. Proc. International Symposium on Controlled Release of Bioactive Materials 23:27-28.
34. Unger, C., Massing, U., Moog, R. (1999). Method for the production of liposomal substance formulations. Application: DE, (Germany), p. 6.